Company
ClaspTx
Revitalizing immuno-oncology’s promise with next-generation T cell engagers
Also known as Clasp Therapeutics, Clasp Therapeutics, Inc
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Clasp Therapeutics, Inc
Claim, correct or request removal
Record updated 28 September 2026
About
Clasp Therapeutics® is expanding the reach of immuno-oncology with precision T cell engagers (TCEs) that enable the immune system to identify and specifically destroy tumors harboring common driver mutations, regardless of tumor type.
Funding snapshot
- Total raised
- $150MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $150M2024-03-20
Funding rounds
- Round, 2024
- $150M2024-03-20, Company stated
Loading relationship preview